Bladder cancer.

BMJ (Clinical research ed.) ·Vol. 317 ·No. 7169 ·1998-11-14 ·Pages 1366-9

van der Meijden AP

Abstract

暂无摘要

MeSH Terms

Chemotherapy, Adjuvant Hematuria/etiology Humans Neoplasm Invasiveness Neoplasm Staging/methods Occupational Exposure/adverse effects Urinary Bladder Neoplasms/diagnosis,etiology,therapy

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

van der Meijden A P

Department of Urology, Bosch Medicentrum, PO Box 90153, 5200 ME 's-Hertogenbosch, Netherlands. urology.bmc@tip.nl

References (16)

16 references, click to expand

Management of invasive bladder neoplasms.
Semin Urol. 1983 Feb;1(1):34-41 PMID: 6433425
A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.
J Urol. 1996 Dec;156(6):1934-40, discussion 1940-1 PMID: 8911360
An overview of intravesical therapy for superficial bladder tumors.
J Urol. 1987 Dec;138(6):1363-8 PMID: 3316712
Bladder cancer in relation to cigarette smoking.
Cancer Res. 1988 Aug 1;48(15):4405-8 PMID: 3390836
Occupational risks of bladder cancer in the United States: II Nonwhite men.
J Natl Cancer Inst. 1989 Oct 4;81(19):1480-3 PMID: 2778835
Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco.
Int J Cancer. 1989 Oct 15;44(4):605-10 PMID: 2793232
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
Cancer. 1989 Dec 15;64(12):2448-58 PMID: 2819654
The current status of adjuvant chemotherapy for bladder cancer.
Semin Urol. 1990 Nov;8(4):291-7 PMID: 2284534
The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial.
J Urol. 1991 Mar;145(3):459-64; discussion 464-7 PMID: 1997689
Cancer in the European Community and its member states.
Eur J Cancer. 1990;26(11-12):1167-256 PMID: 2150000
The ileal neobladder: 6 years of experience with more than 200 patients.
J Urol. 1993 Jul;150(1):40-5 PMID: 8510272
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer.
J Urol. 1995 Aug;154(2 Pt 1):379-83; discussion 383-4 PMID: 7609102
The place of radiation therapy as definitive treatment of bladder cancer.
Int J Urol. 1995 Jun;2 Suppl 2:41-8 PMID: 7553304
The status of bladder-preserving therapeutic strategies in the management of patients with muscle-invasive bladder cancer.
Int J Urol. 1995 Jun;2 Suppl 2:49-57 PMID: 7553305
Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?
Int J Urol. 1995 Jun;2 Suppl 2:76-88 PMID: 7553308
Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.
J Urol. 1996 Aug;156(2 Pt 1):363-7 PMID: 8683680

Article Info

Journal

BMJ (Clinical research ed.)

Abbr.

BMJ

ISSN

0959-8138

DOI

10.1136/bmj.317.7169.1366

urology.bmc@tip.nl

Published

1998-11-14

Pages

1366-9

Language

English

Region

England

NLM ID

8900488

PMCID

PMC1114251

Subset

Corrections

CommentIn

PMID: 10092282

External Links

PubMed source DOI: 10.1136/bmj.317.7169.1366 PMC Full Text

Analysis Services

Bladder cancer.

Contact

WeChat Official Account